These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29696509)

  • 1. Inhibiting IL-2 signaling and the regulatory T-cell pathway using computationally designed peptides.
    Price-Troska T; Yang ZZ; Diller D; Bayden A; Jarosinski M; Audie J; Ansell SM
    Invest New Drugs; 2019 Feb; 37(1):9-16. PubMed ID: 29696509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.
    Yang ZZ; Grote DM; Ziesmer SC; Manske MK; Witzig TE; Novak AJ; Ansell SM
    Blood; 2011 Sep; 118(10):2809-20. PubMed ID: 21719603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum-soluble interleukin-2 receptor in burn patients: characterization and effects on the immune system.
    Jobin N; Garrel D; Bernier J
    Hum Immunol; 2000 Mar; 61(3):233-46. PubMed ID: 10689113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients
    Long D; Yu S; Zhang L; Guo Y; Xu S; Rao Y; Huang Z; Luo Q; Li J
    Front Immunol; 2022; 13():938556. PubMed ID: 36203602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.
    Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE
    Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.
    Kobayashi H; Tagaya Y; Han ES; Kim IS; Le N; Paik CH; Pastan I; Nelson DL; Waldmann TA; Carrasquillo JA
    Cytokine; 1999 Dec; 11(12):1065-75. PubMed ID: 10623432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
    Czystowska M; Strauss L; Bergmann C; Szajnik M; Rabinowich H; Whiteside TL
    J Mol Med (Berl); 2010 Jun; 88(6):577-88. PubMed ID: 20225066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells.
    Tsai MH; Chiou SH; Chow KC
    Int J Oncol; 2001 Nov; 19(5):1049-55. PubMed ID: 11605008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-15 induces the release of soluble IL-2Ralpha from human peripheral blood mononuclear cells.
    Treiber-Held S; Stewart DM; Kurman CC; Nelson DL
    Clin Immunol Immunopathol; 1996 Apr; 79(1):71-8. PubMed ID: 8612353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soluble IL-2 receptor α/CD25 as a modulator of IL-2 function.
    Lokau J; Petasch LM; Garbers C
    Immunology; 2024 Mar; 171(3):377-387. PubMed ID: 38037265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets.
    Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X
    Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effect of GHRH(1-44)NH2 on the secretion of interleukin-2 (IL-2) and soluble IL-2 receptor alpha (sIL-2Ralpha) from human peripheral blood mononuclear cells in vitro].
    Siejka A; Stepień T; Ławnicka H; Krupiński R; Komorowski J; Stepień H
    Endokrynol Pol; 2005; 56(5):773-8. PubMed ID: 16817143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural soluble form of IL-18 receptor beta exacerbates collagen-induced arthritis via modulation of T-cell immune responses.
    Veenbergen S; Smeets RL; Bennink MB; Arntz OJ; Joosten LA; van den Berg WB; van de Loo FA
    Ann Rheum Dis; 2010 Jan; 69(1):276-83. PubMed ID: 19188194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH
    Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
    El Houda Agueznay N; Badoual C; Hans S; Gey A; Vingert B; Peyrard S; Quintin-Colonna F; Ravel P; Bruneval P; Roncelin S; Lelongt B; Bertoglio J; Fridman WH; Brasnu D; Tartour E
    Clin Exp Immunol; 2007 Oct; 150(1):114-23. PubMed ID: 17680822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke.
    Zhao H; Li F; Huang Y; Zhang S; Li L; Yang Z; Wang R; Tao Z; Han Z; Fan J; Zheng Y; Ma Q; Luo Y
    J Neuroinflammation; 2020 Aug; 17(1):237. PubMed ID: 32795376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients.
    Wu P; Miura Y; Hyodoh F; Nishimura Y; Hatayama T; Hatada S; Sakaguchi H; Kusaka M; Katsuyama H; Tomita M; Otsuki T
    Int J Immunopathol Pharmacol; 2006; 19(2):357-68. PubMed ID: 16831302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression.
    Simonetta F; Gestermann N; Bloquet S; Bourgeois C
    PLoS One; 2014; 9(12):e113314. PubMed ID: 25485946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
    Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
    Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metalloprotease ADAM10 generates soluble interleukin-2 receptor alpha (sCD25) in vivo.
    Kirschke S; Ogunsulire I; Selvakumar B; Schumacher N; Sezin T; Rose-John S; Scheffold A; Garbers C; Lokau J
    J Biol Chem; 2022 Jun; 298(6):101910. PubMed ID: 35398356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.